Cyclerion Therapeutics annual depreciation and amortization
2018
2019
2020
2021
2022
2023
Cyclerion Therapeutics Depreciation & Amortization Growth & History (CYCN)
Cyclerion Therapeutics's depreciation and amortization was $0 for fiscal 2023.
View full Cyclerion Therapeutics company overviewCyclerion Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $0 | −$65,000 | — |
| 2022 | 2022-12-31 | $65,000 | −$407,000 | −86.23% |
| 2021 | 2021-12-31 | $472,000 | −$1.8M | −79.45% |
| 2020 | 2020-12-31 | $2.3M | −$403,000 | −14.93% |
| 2019 | 2019-12-31 | $2.7M | $1.2M | +76.70% |
| 2018 | 2018-12-31 | $1.5M | — | — |
Cyclerion Therapeutics quarterly depreciation and amortization
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | −$17,000 | — |
| Q1 2023 | 2023-03-31 | $0 | −$48,000 | — |
| Q3 2022 | 2022-09-30 | $0 | −$600,000 | — |
| Q2 2022 | 2022-06-30 | $17,000 | −$83,000 | −83.00% |
| Q1 2022 | 2022-03-31 | $48,000 | −$210,000 | −81.40% |
| Q3 2021 | 2021-09-30 | $600,000 | $0 | 0.00% |
| Q2 2021 | 2021-06-30 | $100,000 | −$500,000 | −83.33% |
| Q1 2021 | 2021-03-31 | $258,000 | −$368,000 | −58.79% |
| Q3 2020 | 2020-09-30 | $600,000 | −$100,000 | −14.29% |
| Q2 2020 | 2020-06-30 | $600,000 | −$200,000 | −25.00% |
| Q1 2020 | 2020-03-31 | $626,000 | $101,000 | +19.24% |
| Q3 2019 | 2019-09-30 | $700,000 | $300,000 | +75.00% |
| Q2 2019 | 2019-06-30 | $800,000 | $400,000 | +100.00% |
| Q1 2019 | 2019-03-31 | $525,000 | $169,000 | +47.47% |
| Q3 2018 | 2018-09-30 | $400,000 | — | — |
| Q2 2018 | 2018-06-30 | $400,000 | — | — |
| Q1 2018 | 2018-03-31 | $356,000 | — | — |
Cyclerion Therapeutics depreciation and amortization trends
Over the last five fiscal years, Cyclerion Therapeutics's depreciation and amortization decreased from $1.5M to $0, a change of −$1.5M. The latest reported quarter, Q3 2023, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cyclerion Therapeutics source filings ↗